The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 16, 2014

Filed:

Mar. 16, 2010
Applicants:

Paul S. Hoffman, Charlottesville, VA (US);

Richard L. Guerrant, Charlottesville, VA (US);

Timothy L. Macdonald, Charlottesville, VA (US);

Thomas Eric Ballard, Jr., Middletown, CT (US);

Inventors:

Paul S. Hoffman, Charlottesville, VA (US);

Richard L. Guerrant, Charlottesville, VA (US);

Timothy L. Macdonald, Charlottesville, VA (US);

Thomas Eric Ballard, Jr., Middletown, CT (US);

Assignee:

University of Virginia Patent Foundation, Charlottesville, VA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 277/58 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 277/54 (2006.01); C07D 333/42 (2006.01); C07D 409/12 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); C07D 277/54 (2013.01); C07D 417/14 (2013.01); C07D 277/58 (2013.01); C07D 333/42 (2013.01); C07D 409/12 (2013.01);
Abstract

The invention provides novel antimicrobial chemical entities based on a nitrothiazolide backbone that exhibit antibacterial and antiparasitic action against a wide range of human pathogens. The new classes of compounds show extended action against Gram positive bacteria including MRSA drug resistant pathogens. In the Gram-positive organisms, they specifically target and functionally inhibit microbial attachment to surfaces and biofilm formation. In Gram-negative bacteria, including enteroaggregativestrains, these compounds function as pilicides by inhibiting the assembly of pilin subunits into adhesive filaments. Several of these compounds show potent antimicrobial action against Gram positive bacteria, perhaps involving novel targets. Many of the benzothiophene derivatives exhibit antimicrobial activity in the low micrograms per ml range and in blocking biofilm formation in the nanomolar range; ranges considered are well within the range of utility as therapeutics.


Find Patent Forward Citations

Loading…